Showing results (211-220 of 601) with videos related to

Sort By:
Pageof 61
Current Opinion in Neurology|April 16, 2019
Age and the risks of high-efficacy disease modifying drugs in multiple sclerosisFinja Schweitzer, Sarah Laurent, Gereon R Fink, et al.
JAMA Neurology|January 16, 2024
SARS-CoV-2 Vaccination and Neuroimmunological Disease: A ReviewAlice Grizzel Willison, Marc Pawlitzki, Michael Peter Lunn, et al.
Brain and Behavior|September 11, 2015
Isoniazid-induced polyneuropathy in a tuberculosis patient - implication for individual risk stratification with genotyping?Mark Stettner, Daniela Steinberger, Christian J Hartmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2011
Intracranial venous pressure is normal in patients with multiple sclerosisRolf Meyer-Schwickerath, Christian Haug, Annette Hacker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 2018
Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatmentJonas Graf, Marius Ringelstein, Klaudia Lepka, et al.
Archives of Neurology|February 11, 2009
Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosisOlaf Stüve, Verena I Leussink, Ruth Fröhlich, et al.
Clinical Therapeutics|December 4, 2012
GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical studyFrançois Curtin, Alois B Lang, Hervé Perron, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2008
The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelinationAndré Heinen, David Kremer, Peter Göttle, et al.
Archives of Neurology|July 4, 2012
Fingolimod impedes Schwann cell-mediated myelination: implications for the treatment of immune neuropathies?Angelika Köhne, Mark Stettner, Parastoo Jangouk, et al.
Frontiers in Immunology|August 15, 2022
The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosisEduardo Duarte-Silva, Henning Ulrich, Ágatha Oliveira-Giacomelli, et al.
Pageof 61